Home › Funds › T. Rowe Price › T. Rowe Price Equity Index 500 Fund
Fund family: T. Rowe Price · Filed by T. Rowe Price Index Trust, Inc. (CIK 858581) · SEC series S000002089
Share classes and tickers: PREIX (C000005457), PRUIX (C000159677), TRHZX (C000219327)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 6,232 with, 334 against, 0 abstentions (not counted as with management); 5 items carried no recommendation. Shareholder proposals: 30 FOR, 309 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | T. Rowe Price | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 96.1% | 6,089 | 93.7% | 208,710 |
| Backed environmental and social shareholder proposals at US companies | 4.1% | 148 | 2.6% | 3,333 |
Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most T. Rowe Price funds on 2 items (0.1% of the 5,509 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Molina Healthcare, Inc. | 2026-05-06 | To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. | For | AGAINST — 11 of 17 T. Rowe Price funds | For | Passed (calculated), 52.8% support |
| Bio-Techne Corporation | 2025-10-30 | Approve, on an advisory basis, the compensation of our executive officers. | For | AGAINST — 8 of 13 T. Rowe Price funds | For | Approved, 72.1% support |
Download all 2 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 99.6% of this fund’s 6,566 such votes could be given a sector; the other 27 (0.4%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 1,305 | 87 | 6.7% |
| Industrials | 1,041 | 44 | 4.2% |
| Finance | 994 | 38 | 3.8% |
| Technology | 935 | 78 | 8.3% |
| Health Care | 712 | 32 | 4.5% |
| Utilities | 489 | 16 | 3.3% |
| Real Estate | 334 | 2 | 0.6% |
| Consumer Staples | 317 | 20 | 6.3% |
| Energy | 213 | 7 | 3.3% |
| Telecommunications | 132 | 9 | 6.8% |
| Basic Materials | 67 | 1 | 1.5% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 4,830 | 0 |
| Say-on-Pay | 514 | 0 |
| Audit-related | 500 | 0 |
| Corporate Governance | 292 | 159 |
| Compensation | 177 | 11 |
| Capital Structure | 74 | 0 |
| Environment or Climate | 66 | 66 |
| Other Social Issues | 57 | 57 |
| Extraordinary Transactions | 27 | 1 |
| Shareholder Rights and Defenses | 27 | 15 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Apple Inc. | February 24, 2026 | $3.4B | 12 | 1 |
| Microsoft Corporation | December 5, 2025 | $2.5B | 21 | 6 |
| NVIDIA Corporation | June 24, 2026 | $2.4B | 16 | 4 |
| Meta Platforms, Inc. | May 27, 2026 | $1.7B | 22 | 9 |
| Amazon.com, Inc. | May 20, 2026 | $1.6B | 17 | 4 |
| Alphabet Inc. | June 5, 2026 | $1.0B | 23 | 10 |
| Broadcom Inc. | April 20, 2026 | $988M | 10 | 0 |
| Eli Lilly and Company | May 4, 2026 | $714M | 10 | 2 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding a report on water usage and AI development Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
6,590 ballot items at 516 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, T. Rowe Price Equity Index 500 Fund (PREIX) voted at 516 shareholder meetings of 495 companies, on 6,590 ballot items in all. Where management made a recommendation, the fund followed it on 94.9% of the items and voted against it 334 times. Its most frequent area of disagreement was corporate governance (159 of its votes against management). It voted FOR 8.8% of the 339 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than T. Rowe Price's funds as a whole (96.1% against 93.7%). It voted differently from most T. Rowe Price funds on 2 items. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.